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Stem cells are defined by their unique ability to self-renew
and their multipotent differentiation capacity, thus main-
taining tissue homeostasis throughout the life of a multi-
cellular organism. Stem cells reside in niches characterized
by hypoxia and low reactive oxygen species (ROS), both
of which are critical for maintaining the potential for self-
renewal and stemness. Until recently, the focus in stem cell
biology has been on the adverse effects of ROS, particularly
the damaging effects of ROS accumulation on tissue aging
and the development of cancer. However, it has become
increasingly clear that, in some cases, redox status plays an
important role in stem cell maintenance, that is, regulation
of the cell cycle. In fact, ROS at low levels function as
signaling molecules to mediate cell proliferation, migration,
and differentiation and gene expression. ROS levels in stem
and progenitor cells have a clear correlation with cellular
functions and are regulated by a fine-tuning of the balance
between ROS-generating and antioxidant defense systems.
This special issue tries to fully decipher the underlying
molecular mechanisms involved in the maintenance of stem
cell self-renewal, which is critical to address the important
role of redox homeostasis in the regulation of both self-
renewal and differentiation of stem cells.
The safe use of stem cells for clinical applications still
requires culture improvements to obtain functional cells.The
review of S. Sart et al. investigates the roles of ROS in the
maintenance of self-renewal, proliferation, and differentia-
tion of mesenchymal stem cells (MSCs) and pluripotent stem
cells (PSCs) and highlights that the tight control of stem cell
microenvironment, including cell organization, metabolic,
and mechanical environments, may be an effective approach
to regulate endogenous ROS generation. While high levels
of ROS have detrimental effects on stem cells through the
induction of oxidative stress, physiological levels of ROS
play an important role in the regulation of stem cell fate
decision. Mild levels of ROS act as secondary messengers by
interferingwith various signaling pathways that regulate stem
cell proliferation, survival, and differentiation. However, the
contribution of the specific site of ROS production and the
specific type of ROS to the regulation of stem cell fate requires
further delineation. In addition, the exact threshold levels
of ROS discerning between the role as damaging molecules
or as enhancers of stem cell signaling pathway are not
clearly defined. Combined with accurate ROS measurement,
regulation of biochemical and biomechanical environment of
stem cells to modulate redox status can lead to the controlled
proliferation and differentiation of stem cells towards various
biomedical applications.
Regarding the site of ROS production and the damaging
role of ROS in human stem cells the article of T. Maraldi
et al. suggests a particular role of NAD(P)H oxidase enzyme
family. In this study they show that Nox4 nuclear expression
depends on the donor and it correlates with the expression
of redox transcription factors involved in stemness regula-
tion and with the differentiation potential. Taken together,
these results suggest that nuclear Nox4 regulation may have
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important effects on stem cell capability through modulation
of transcription factors and DNA damage and the extensive
donor-to-donor heterogeneity.
The study of O. G. Lyublinskaya et al. focuses on the
involvement of ROS in the process of MSCs “waking up”
and entering the cell cycle after the quiescence. Using human
endometrial MSCs, they showed that intracellular basal ROS
levels are positively correlated with the proliferative status of
the cell cultures. In fact, they observed that physiologically
relevant levels of ROS are required for the initiation of human
MSC proliferation and that low levels of ROS due to the
antioxidant treatment can block the stem cell self-renewal.
Despite many attractive advantages of MSCs, replicative
senescence of MSCs occurs, eventually decreasing their
functional capacities. MSC aging is proposed to potentially
contribute to organism aging leading to loss of tissue home-
ostasis. It is essential to consider the role of ROS in the
aging process of MSCs since MSCs and their regenerative
potential have revealed a critical therapeutic approach to
aging. In lung diseases, the excessive amount of ROS from
the ambient air might be associated with respiratory failure
through unsuspected mechanisms that regulate declines in
the residual stem cell function with age. However, the review
of S.-R. Yang concludes that much work remains to be done
to understand the ROS-mediated mechanisms that regulate
residual stem cells. Elucidating these mechanisms will be
critical to understand how stem cell based or antioxidant
therapies are effective in certain tissues including lungs.
Regarding the role of ROS in the differentiation pro-
cess the article of S. Kostyuk et al. describes that GC-rich
fragments in the pool of cell-free DNA (cfDNA), circu-
lating throughout the bloodstream of both healthy people
and patients with various diseases, can potentially induce
oxidative stress and DNA damage response and affect the
direction of MSCs differentiation in human adipose-derived
MSCs. Such a response may be one of the causes of obesity or
osteoporosis.
Similar to normal stem cells, cancer stem cells (CSCs)
also show lower intracellular ROS levels, suggesting that
maintenance of a reduced intracellular environment is asso-
ciated with an undifferentiated state. CSCs are responsible
for cancer recurrence after chemotherapy or radiotherapy.
However, the role of ROS inCSCs remains poorly understood
and intensive research is desperately needed.
The review of S. Ding focuses on ROS generation and
removal in CSCs and their effects on CSC self-renewal and
differentiation through the modulating of ROS-dependent
cellular processes. While information on ROS regulation in
CSCs are limited, there is fast emerging evidence that ROS
may play essential role in the self-renew and differentiation
ability of CSCs. The review concludes that targeting CSCs
via ROS and antioxidant enzymes regulation holds a great
promise in cancer therapy.
Similarly, the review of J. Liu and Z. Wang analyses the
particular role of ROS in CSCs. Increasing evidence proposes
that a low concentration of ROS can maintain the stemness
of CSCs and contribute to tumorigenesis and development.
Various systems exist for the regulation of ROS in CSCs.
For example, under hypoxic environment, increased levels
of ROS induce the expression of HIFs in CSCs, resulting
in the upregulation of CSC markers and the reduction of
intracellular ROS level and thus facilitatingCSCs survival and
proliferation. Consequently, the induction of oxidative stress
appears to be a promising approach for the preferential killing
of cancer cells, including CSCs. In addition, a more detailed
investigation of therapies with direct or indirect effects on
ROSwill help to define amade-to-order therapeutic schedule
with a lower tendency toward promoting the development of
resistance to treatment.
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